fda sued over tirzepatide Eli Lilly sues companies selling alternative versions of its weight loss drug FDA Says Compounded Tirzepatide Must

Wu J, Yan LJ

The blend is sold for research use only and is not FDA-approved as a combination product

For example, other antidiabetic agents (such as insulin, metformin, glyburide, sitagliptin, and canagliflozin) taken along with GLP-1 RAs potentiate hypoglycemic risk and may necessitate dose adjustments

Making This Work in the Real World I want to close with something I tell every patient at their first follow-up: the goal here isn't perfection

For emergency situations, call 911 immediately if you experience signs of anaphylaxis (severe allergic reaction with hives, difficulty breathing, swelling of face/throat), severe breathing difficulty, or sudden severe abdominal pain that may indicate pancreatitis